Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0096 | 0.2536 | 0.8973 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0093 | 0.2381 | 0.8425 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0093 | 0.2381 | 0.2381 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0103 | 0.2826 | 1 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0103 | 0.2826 | 1 |
Trypanosoma brucei | cdc2-related kinase 3 | 0.0093 | 0.2381 | 0.7381 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0064 | 0.1126 | 0.2853 |
Echinococcus multilocularis | cyclin B | 0.0064 | 0.1126 | 0.1126 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0093 | 0.2381 | 0.7381 |
Giardia lamblia | Kinase, CMGC GSK | 0.0103 | 0.2826 | 1 |
Onchocerca volvulus | 0.0103 | 0.2826 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0064 | 0.1126 | 0.1126 |
Loa Loa (eye worm) | CMGC/DYRK/DYRK1 protein kinase | 0.0096 | 0.2536 | 0.2536 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0093 | 0.2381 | 0.2381 |
Giardia lamblia | Kinase, CMGC GSK | 0.0103 | 0.2826 | 1 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0103 | 0.2826 | 0.2826 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0103 | 0.2826 | 1 |
Trichomonas vaginalis | cyclin B, putative | 0.0064 | 0.1126 | 0.3985 |
Schistosoma mansoni | cyclin-dependent kinase 5 activator | 0.027 | 1 | 1 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0093 | 0.2381 | 0.8425 |
Trichomonas vaginalis | cyclin B, putative | 0.0064 | 0.1126 | 0.3985 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0093 | 0.2381 | 0.2381 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0103 | 0.2826 | 1 |
Trichomonas vaginalis | cyclin B, putative | 0.0064 | 0.1126 | 0.3985 |
Entamoeba histolytica | protein kinase, putative | 0.0096 | 0.2536 | 0.8973 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0103 | 0.2826 | 1 |
Trichomonas vaginalis | cyclins, putative | 0.0064 | 0.1126 | 0.3985 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0093 | 0.2381 | 0.7381 |
Echinococcus granulosus | cyclin dependent kinase 1 | 0.0093 | 0.2381 | 0.2381 |
Brugia malayi | Protein kinase domain containing protein | 0.0096 | 0.2536 | 0.6425 |
Loa Loa (eye worm) | hypothetical protein | 0.027 | 1 | 1 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0093 | 0.2381 | 0.2381 |
Trypanosoma cruzi | CMGC/DYRK protein kinase, putative | 0.0096 | 0.2536 | 0.8293 |
Trypanosoma brucei | CMGC/DYRK protein kinase, putative | 0.0096 | 0.2536 | 0.8293 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0103 | 0.2826 | 0.2826 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0103 | 0.2826 | 0.2826 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0103 | 0.2826 | 0.2826 |
Brugia malayi | Protein kinase domain containing protein | 0.0093 | 0.2381 | 0.6032 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.2263 | 0.2263 |
Trichomonas vaginalis | cyclins, putative | 0.0064 | 0.1126 | 0.3985 |
Entamoeba histolytica | protein kinase, putative | 0.0096 | 0.2536 | 0.8973 |
Echinococcus multilocularis | cyclin dependent kinase 5 | 0.0093 | 0.2381 | 0.2381 |
Trichomonas vaginalis | cyclins, putative | 0.0064 | 0.1126 | 0.3985 |
Trypanosoma cruzi | CMGC/DYRK protein kinase, putative | 0.0096 | 0.2536 | 0.8293 |
Echinococcus multilocularis | dual specificity | 0.0096 | 0.2536 | 0.2536 |
Trichomonas vaginalis | cyclin B, putative | 0.0064 | 0.1126 | 0.3985 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0093 | 0.2381 | 0.7381 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0093 | 0.2381 | 0.8425 |
Plasmodium falciparum | protein kinase 5 | 0.0093 | 0.2381 | 0.8425 |
Giardia lamblia | Kinase, CMGC CDK | 0.0093 | 0.2381 | 0.8425 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0103 | 0.2826 | 1 |
Echinococcus granulosus | 5'partial|cyclin dependent kinase 1 | 0.0093 | 0.2381 | 0.2381 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0103 | 0.2826 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.3948 | 0.3948 |
Leishmania major | cell division protein kinase 2,cdc2-related kinase | 0.0093 | 0.2381 | 0.7381 |
Giardia lamblia | G2/mitotic-specific cyclin B | 0.0064 | 0.1126 | 0.3985 |
Trichomonas vaginalis | cyclin A, putative | 0.0064 | 0.1126 | 0.3985 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0093 | 0.2381 | 0.8425 |
Trypanosoma brucei | cdc2-related kinase 1 | 0.0093 | 0.2381 | 0.7381 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.2418 | 0.2418 |
Trypanosoma brucei | protein kinase, putative | 0.0103 | 0.2826 | 1 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.0103 | 0.2826 | 1 |
Giardia lamblia | Kinase, CMGC CDK | 0.0093 | 0.2381 | 0.8425 |
Echinococcus granulosus | cyclin B | 0.0064 | 0.1126 | 0.1126 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0093 | 0.2381 | 0.2381 |
Leishmania major | serine/threonine-protein kinase, putative,protein kinase, putative | 0.0096 | 0.2536 | 0.8293 |
Entamoeba histolytica | protein kinase, putative | 0.0103 | 0.2826 | 1 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0064 | 0.1126 | 0.2853 |
Brugia malayi | intracellular kinase | 0.0103 | 0.2826 | 0.716 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.3948 | 0.3948 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.2418 | 0.2418 |
Echinococcus multilocularis | cyclin dependent kinase | 0.0093 | 0.2381 | 0.2381 |
Brugia malayi | hypothetical protein | 0.0129 | 0.3948 | 1 |
Echinococcus granulosus | cyclin dependent kinase 5 | 0.0093 | 0.2381 | 0.2381 |
Echinococcus granulosus | dual specificity | 0.0096 | 0.2536 | 0.2536 |
Echinococcus multilocularis | protein kinase shaggy | 0.0103 | 0.2826 | 0.2826 |
Loa Loa (eye worm) | hypothetical protein | 0.0064 | 0.1126 | 0.1126 |
Entamoeba histolytica | cyclin, putative | 0.0064 | 0.1126 | 0.3985 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0103 | 0.2826 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0096 | 0.2536 | 0.8973 |
Loa Loa (eye worm) | CMGC/CDK/CDK5 protein kinase | 0.0093 | 0.2381 | 0.2381 |
Trichomonas vaginalis | cyclins, putative | 0.0064 | 0.1126 | 0.3985 |
Echinococcus granulosus | protein kinase shaggy | 0.0103 | 0.2826 | 0.2826 |
Echinococcus granulosus | cyclin dependent kinase | 0.0093 | 0.2381 | 0.2381 |
Echinococcus multilocularis | cyclin dependent kinase 5 activator 1 | 0.027 | 1 | 1 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0093 | 0.2381 | 0.8425 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0103 | 0.2826 | 0.2826 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0096 | 0.2536 | 0.2536 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0093 | 0.2381 | 0.7381 |
Brugia malayi | cell division control protein 2 homolog | 0.0093 | 0.2381 | 0.6032 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0093 | 0.2381 | 0.2381 |
Schistosoma mansoni | cyclin B | 0.0064 | 0.1126 | 0.1126 |
Leishmania major | cell division related protein kinase 2,cdc2-related kinase | 0.0093 | 0.2381 | 0.7381 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | Inhibition of mPGES-1 in IL-1beta-stimulated human A549 cell microsomal membranes assessed as reduction in PGE2 formation incubated for 15 mins using PGH2 substrate by RP-HPLC method | ChEMBL. | 26088337 | |
Inhibition (binding) | <= 0 % | Inhibition of mPGES-1 derived from IL1beta and TNFalpha stimulated human HeLa cells microsomal fraction using PGH2 as substrate at 1 uM preincubated for 30 mins prior to substrate addition measured after 1 min by LC-MS/MS analysis relative to control | ChEMBL. | 22449023 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.